Well I didn't see that trial announcement coming, or that Patent Grant. Combine those with the trials running at Dana Farber and Harvard, and the filing last week about a non-disclosure being filed with a prominent Southwestern Cancer center (probably MD Anderson), and Cellceutix is looking like an incredible find at this price. I wonder what happens when Institutional investors find out about this stock? Or even just individuals investors? It feels pretty good to own an undiscovered stock with 10x upside potential!
I just read the SA article today on CTIX and wondered why it's on the OTC at this share price? I own NBS at .61/share yet it's on the NYSE MKT exchange. Haven't had time yet to sift through all the background. Based on the latest PRs, am ready to jump in. Cheers, Bob